Therma Bright Inc. (TBRIF)
USD 0.02
(-0.93%)
USD 0.02
(-0.93%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -91.84 Thousand CAD | 96.91% |
| 2022 | -2.97 Million CAD | -70.68% |
| 2021 | -1.74 Million CAD | -80.24% |
| 2020 | -965.82 Thousand CAD | -1807.32% |
| 2019 | 56.57 Thousand CAD | 293.85% |
| 2018 | -29.18 Thousand CAD | -114.24% |
| 2017 | 204.9 Thousand CAD | -73.54% |
| 2016 | 774.42 Thousand CAD | 5.56% |
| 2015 | 733.66 Thousand CAD | -84.33% |
| 2014 | 4.68 Million CAD | 18.26% |
| 2013 | 3.95 Million CAD | 15.82% |
| 2012 | 3.41 Million CAD | 16.07% |
| 2011 | 2.94 Million CAD | 0.0% |
| 2009 | 2.17 Million CAD | 19.37% |
| 2008 | 1.82 Million CAD | 17.85% |
| 2007 | 1.54 Million CAD | 43.84% |
| 2006 | 1.07 Million CAD | 266.46% |
| 2005 | 293.55 Thousand CAD | 210.56% |
| 2004 | -265.51 Thousand CAD | -63.86% |
| 2003 | -162.03 Thousand CAD | 64.75% |
| 2002 | -459.65 Thousand CAD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 77.45 Thousand CAD | -6.95% |
| 2024 Q1 | 83.24 Thousand CAD | 190.63% |
| 2024 Q3 | 72.05 Thousand CAD | -6.98% |
| 2023 Q1 | -2.5 Million CAD | 15.71% |
| 2023 Q3 | -7653.00 CAD | 99.18% |
| 2023 Q4 | -91.84 Thousand CAD | -1100.14% |
| 2023 Q2 | -933.61 Thousand CAD | 62.72% |
| 2023 FY | -91.84 Thousand CAD | 96.91% |
| 2022 Q1 | -794.49 Thousand CAD | 54.36% |
| 2022 FY | -2.97 Million CAD | -70.68% |
| 2022 Q4 | -2.97 Million CAD | 33.78% |
| 2022 Q2 | -213.67 Thousand CAD | 73.11% |
| 2022 Q3 | -4.48 Million CAD | -1999.76% |
| 2021 Q1 | -281.9 Thousand CAD | 70.81% |
| 2021 Q4 | -1.74 Million CAD | 15.22% |
| 2021 Q3 | -2.05 Million CAD | -26.4% |
| 2021 Q2 | -1.62 Million CAD | -476.31% |
| 2021 FY | -1.74 Million CAD | -80.24% |
| 2020 Q2 | 148.31 Thousand CAD | 77.98% |
| 2020 Q3 | 181.05 Thousand CAD | 22.08% |
| 2020 FY | -965.82 Thousand CAD | -1807.32% |
| 2020 Q4 | -965.82 Thousand CAD | -633.43% |
| 2020 Q1 | 83.33 Thousand CAD | 47.31% |
| 2019 Q1 | -20.96 Thousand CAD | 28.17% |
| 2019 Q2 | 58.1 Thousand CAD | 377.22% |
| 2019 Q3 | 88.75 Thousand CAD | 52.74% |
| 2019 Q4 | 56.57 Thousand CAD | -36.26% |
| 2019 FY | 56.57 Thousand CAD | 293.85% |
| 2018 FY | -29.18 Thousand CAD | -114.24% |
| 2018 Q1 | 274.89 Thousand CAD | 34.16% |
| 2018 Q3 | -269.67 Thousand CAD | -1052.4% |
| 2018 Q2 | 28.31 Thousand CAD | -89.7% |
| 2018 Q4 | -29.18 Thousand CAD | 89.18% |
| 2017 FY | 204.9 Thousand CAD | -73.54% |
| 2017 Q2 | 797.96 Thousand CAD | 4.05% |
| 2017 Q3 | 401.64 Thousand CAD | -49.67% |
| 2017 Q4 | 204.9 Thousand CAD | -48.98% |
| 2017 Q1 | 766.89 Thousand CAD | -0.97% |
| 2016 FY | 774.42 Thousand CAD | 5.56% |
| 2016 Q1 | 747.3 Thousand CAD | 1.86% |
| 2016 Q3 | 765.54 Thousand CAD | 0.25% |
| 2016 Q2 | 763.59 Thousand CAD | 2.18% |
| 2016 Q4 | 774.42 Thousand CAD | 1.16% |
| 2015 Q2 | 727.45 Thousand CAD | -85.11% |
| 2015 Q4 | 733.66 Thousand CAD | 0.49% |
| 2015 FY | 733.66 Thousand CAD | -84.33% |
| 2015 Q1 | 4.88 Million CAD | 4.31% |
| 2015 Q3 | 730.07 Thousand CAD | 0.36% |
| 2014 Q4 | 4.68 Million CAD | 3.86% |
| 2014 Q2 | 4.34 Million CAD | 4.48% |
| 2014 Q1 | 4.15 Million CAD | 4.92% |
| 2014 Q3 | 4.5 Million CAD | 3.88% |
| 2014 FY | 4.68 Million CAD | 18.26% |
| 2013 Q4 | 3.95 Million CAD | 2.53% |
| 2013 Q2 | 3.72 Million CAD | 4.84% |
| 2013 Q1 | 3.55 Million CAD | 3.85% |
| 2013 FY | 3.95 Million CAD | 15.82% |
| 2013 Q3 | 3.86 Million CAD | 3.74% |
| 2012 Q4 | 3.41 Million CAD | 0.0% |
| 2012 FY | 3.41 Million CAD | 16.07% |
| 2011 FY | 2.94 Million CAD | 0.0% |
| 2010 Q2 | 2.28 Million CAD | 1.15% |
| 2010 Q3 | 2.4 Million CAD | 5.45% |
| 2010 Q1 | 2.25 Million CAD | 3.59% |
| 2009 FY | 2.17 Million CAD | 19.37% |
| 2009 Q4 | 2.17 Million CAD | -42.32% |
| 2009 Q1 | 1.94 Million CAD | 6.68% |
| 2009 Q3 | 3.77 Million CAD | 4.76% |
| 2009 Q2 | 3.6 Million CAD | 85.18% |
| 2008 Q2 | 1.73 Million CAD | 7.54% |
| 2008 FY | 1.82 Million CAD | 17.85% |
| 2008 Q4 | 1.82 Million CAD | 0.38% |
| 2008 Q3 | 1.81 Million CAD | 4.77% |
| 2008 Q1 | 1.61 Million CAD | 4.21% |
| 2007 Q1 | 1.22 Million CAD | 14.31% |
| 2007 Q2 | 1.34 Million CAD | 9.71% |
| 2007 FY | 1.54 Million CAD | 43.84% |
| 2007 Q3 | 1.45 Million CAD | 7.61% |
| 2007 Q4 | 1.54 Million CAD | 6.58% |
| 2006 Q4 | 1.07 Million CAD | -0.12% |
| 2006 Q3 | 1.07 Million CAD | 87.47% |
| 2006 FY | 1.07 Million CAD | 266.46% |
| 2006 Q2 | 574.51 Thousand CAD | 33.62% |
| 2006 Q1 | 429.95 Thousand CAD | 46.46% |
| 2005 FY | 293.55 Thousand CAD | 210.56% |
| 2005 Q3 | -1930.00 CAD | 98.03% |
| 2005 Q1 | -263.15 Thousand CAD | 0.0% |
| 2005 Q2 | -97.78 Thousand CAD | 62.84% |
| 2005 Q4 | 293.55 Thousand CAD | 15310.21% |
| 2004 Q2 | 27.49 Thousand CAD | 3.26% |
| 2004 FY | -265.51 Thousand CAD | -63.86% |
| 2004 Q1 | 26.62 Thousand CAD | 272.18% |
| 2004 Q3 | -319.75 Thousand CAD | -1263.04% |
| 2003 FY | -162.03 Thousand CAD | 64.75% |
| 2003 Q1 | -162.03 Thousand CAD | 52.85% |
| 2003 Q4 | 7154.00 CAD | -75.32% |
| 2003 Q3 | 28.98 Thousand CAD | 161.32% |
| 2003 Q2 | -47.26 Thousand CAD | 70.83% |
| 2002 FY | -459.65 Thousand CAD | 0.0% |
| 2002 Q3 | -266.18 Thousand CAD | -76.45% |
| 2002 Q4 | -343.69 Thousand CAD | -29.12% |
| 2002 Q2 | -150.85 Thousand CAD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Manhattan Scientifics, Inc. | -7000.00 USD | -1212.1% |
| SS Innovations International, Inc. | 1.18 Million USD | 107.749% |
| Össur hf. | 395.08 Million USD | 100.023% |
| Össur hf. | 395.08 Million USD | 100.023% |
| CVR Medical Corp. | - USD | Infinity% |
| Bionovate Technologies Corp | - USD | Infinity% |
| QHSLab, Inc. | 1.72 Million USD | 105.309% |
| BrainsWay Ltd. | -10.32 Million USD | 99.11% |
| BioElectronics Corporation | 14.82 Million USD | 100.619% |
| AVITA Medical, Inc. | -26.23 Million USD | 99.65% |
| Zecotek Photonics Inc. | 2.76 Million USD | 103.325% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| Wellstar International, Inc. | 51.36 Million USD | 100.179% |
| Hamilton Thorne Ltd. | 18.12 Million USD | 100.507% |
| EKF Diagnostics Holdings plc | -4.61 Million USD | 98.011% |
| Escalon Medical Corp. | 315.68 Thousand USD | 129.094% |
| Aurora Spine Corporation | 1.9 Million USD | 104.815% |
| NewCardio, Inc. | 2.41 Million USD | 103.803% |
| Avitar, Inc. | 5.17 Million USD | 101.776% |
| Vivos Inc. | -1.59 Million USD | 94.232% |
| Theraclion SA | -5.86 Million EUR | 98.434% |
| Kelyniam Global, Inc. | 487.33 Thousand USD | 118.847% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| REMSleep Holdings, Inc. | -540.98 Thousand USD | 83.022% |
| Positron Corporation | 1.68 Million USD | 105.445% |
| CYduct Diagnostics, Inc. | 640.19 Thousand USD | 114.347% |
| Nanomix Corporation | 11.38 Million USD | 100.806% |
| Wellness Center USA, Inc. | 3.98 Million USD | 102.305% |
| Stratec SE | 119.12 Million USD | 100.077% |
| Heart Tronics, Inc. | 54.99 Thousand USD | 267.01% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Nu-Med Plus, Inc. | 93.19 Thousand USD | 198.555% |
| Electromedical Technologies, Inc. | 1.61 Million USD | 105.702% |
| Lombard Medical, Inc. | 11.49 Million USD | 100.799% |
| ALR Technologies Inc. | 19.14 Million USD | 100.48% |
| MicroPort Scientific Corporation | 673.58 Million USD | 100.014% |
| Vycor Medical, Inc. | 1.05 Million USD | 108.723% |
| VMS Rehab Systems, Inc. | 133.52 USD | 68888.945% |
| Perimeter Medical Imaging AI, Inc. | -13.78 Million USD | 99.334% |
| Guided Therapeutics, Inc. | 1.46 Million USD | 106.261% |
| SANUWAVE Health, Inc. | 30.14 Million USD | 100.305% |
| Ingen Technologies, Inc. | 630.91 Thousand USD | 114.558% |
| United American Healthcare Corporation | -9.32 Million USD | 99.015% |
| Odyssey Group International, Inc. | 2.1 Million USD | 104.357% |
| IR-Med Inc. | -606 Thousand USD | 84.844% |
| Polarean Imaging plc | -5.94 Million USD | 98.455% |
| ECGI Holdings, Inc. | 3.17 Million USD | 102.896% |
| Capital Group Holdings, Inc. | -3508.00 USD | -2518.216% |
| ADM Tronics Unlimited, Inc. | 262.61 Thousand USD | 134.974% |
| Medical Supply International USA, Inc. | 216.6 Thousand USD | 142.402% |
| Urologix, Inc. | 4.61 Million USD | 101.99% |
| Rapid Therapeutic Science Laboratories, Inc. | 4.2 Million USD | 102.182% |
| Nexeon MedSystems Inc. | 3.33 Million USD | 102.757% |
| Qualis Innovations, Inc. | 6671.00 USD | 1476.81% |
| Smith & Nephew plc | 2.77 Billion USD | 100.003% |
| NIOX Group Plc | -23.93 Million USD | 99.616% |
| Fuse Medical, Inc. | 1.75 Million USD | 105.232% |
| Broncus Holding Corporation | -81.42 Million USD | 99.887% |
| Brain Scientific Inc. | 2.11 Million USD | 104.341% |
| Pressure BioSciences, Inc. | 22.67 Million USD | 100.405% |
| Health Logic Interactive Inc. | 39.55 Thousand USD | 332.189% |